Dr. Babak Baban is a highly accomplished researcher and has been studying CBD and cannabinoids at the Dental College of Georgia at Augusta University for years where he is Associate Dean for Research, a professor and immunologist. One of Dr. Baban’s studies on how CBD helps reduce cytokine storms in COVID-19 made headlines last year, and that’s how we first noticed his work.
More recently, I was blown away by a revolutionary study on mice that had severe familial Alzheimer’s Disease. Two weeks of high dose CBD seemed to reset how proteins are made in those Alzheimer’s impacted mouse brains!
Dr. Baban has published more than 100 peer-reviewed articles, presented at dozens of national and international research conferences and has served on international study sections and editorial review boards. He is a member of the American Association for Cancer Research, American Heart Association, and the International Cannabinoid Research Society among others.
Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease
Journal of Alzheimer’s Disease, 2021 https://pubmed.ncbi.nlm.nih.gov/33612548/
A Scripps Research study published in the journal Molecular Pharmaceutics in August 2006, “A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology”
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome CBD normalizes lung function
Neurological consequences of COVID-19: what have we learned and where do we go from here?
#Cannabis #Dementia #Alzheimers
Copyright 2021 Coennen Creative All Rights Reserved.